British American Tobacco (BTI) has suspended the rollout of a disposable vape in the US after the FDA increased efforts to regulate unlicensed products. This move highlights the challenges major tobacco companies face in a market saturated with unregulated products, impacting profits in the $22 billion US smoking alternatives market.

Reynolds American, BAT’s US arm, decided to pause the pilot launch of Vuse One, an unlicensed product acquired in April. This decision, although a pilot, signaled a shift in how big tobacco companies interact with FDA regulations, attracting attention from investors, competitors, and regulators alike.

British American Tobacco p.l.c. (NYSE:BTI) is a British multinational company known for producing cigarettes, tobacco, and related products. While BTI shows investment potential, other AI stocks may offer greater upside potential with less downside risk in the current market climate.

Investors are encouraged to explore alternative AI stocks with significant potential amidst changing market dynamics. Check out our report on the best short-term AI stock for a deeper insight into investment opportunities beyond BTI.

Read more at Yahoo Finance: British American Tobacco (BTI) Suspends U.S. Vape Rollout Following Regulatory Pressure